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Volume-regulated anion channels (VRACs) are crucial for cell
volume regulation and have various roles in physiology and
pathology. VRACs were recently discovered to be formed by
heteromers of leucine-rich repeat– containing 8 (LRRC8) pro-
teins. However, the structural determinants of VRAC perme-
ation and gating remain largely unknown. We show here that
the short stretch preceding the first LRRC8 transmembrane
domain determines VRAC conductance, ion permeability, and
inactivation gating. Substituted-cysteine accessibility studies
revealed that several of the first 15 LRRC8 residues are function-
ally important and exposed to a hydrophilic environment. Sub-
stituting glutamate 6 with cysteine decreased the amplitudes of
swelling-activated ICl,vol currents, strongly increased iodide-
over-chloride permeability, and markedly shifted the voltage
dependence of channel inactivation. Importantly, these effects
were reversed by 2-sulfonatoethyl methanethiosulfonate, which
restores the negative charge at this amino acid position. Cd2-
mediated blocking of ICl,vol in cysteine variants suggested that
the LRRC8 N termini come close together in the multimeric
channel complex and might form part of the pore. We propose a
model in which the N termini of the LRRC8 subunits line the
cytoplasmic portion of the VRAC pore, possibly by folding back
into the ion permeation pathway.
Maintenance of a constant volume upon changes in extracel-
lular or intracellular osmolarity is critical for the function and
survival of cells (1). After swelling, cells readjust their volume
in a process called regulatory volume decrease, which involves
the regulated passive efflux of chloride, potassium, and small
organic compounds that osmotically drive the outflow of water.
A key player in regulatory volume decrease is the volume-reg-
ulated anion channel (VRAC),4 which is also known as volume-
sensitive outwardly rectifying anion channel (VSOR) (2) or vol-
ume-sensitive organic osmolyte-anion channel (VSOAC) (3).
VRACs seem to be ubiquitously expressed in vertebrate cells.
They not only transport chloride but also various molecules,
including organic osmolytes, neurotransmitters, and drugs (1,
4 –7). Besides regulating cell volume, VRAC may play roles in
signal transduction, cell migration, apoptosis, tumor drug resis-
tance, and stroke (1, 5, 8).
VRAC currents (named ICl,vol or ICl,swell) were first reported
nearly 30 years ago (9, 10) and have been extensively characterized
since then (11, 12). VRACs are largely closed under resting condi-
tions. Their opening by cell swelling, which may involve several
poorly understood mechanisms, leads to typical anion currents
that display an SCN  I  NO3  Br  Cl  F permea-
bility sequence, variable inactivation at cytoplasmic positive
potentials, and moderate outward rectification (1, 11–13).
Our ignorance of the proteins mediating ICl,vol (2, 14) has
precluded structure–function analyses of VRAC until recently
when the channel was found to be composed of heteromers of
LRRC8 proteins (4). LRRC8A, the only essential VRAC subunit
(4, 15), needs at least one of the other proteins (LRRC8B, -C, -D,
or -E) encoded by the LRRC8 gene family to form functional
channels (4). Instead of a single VRAC, there are a large number
of differently composed VRACs, taking into account that
LRRC8 proteins assemble to hexamers (4, 16, 17) or higher-
order oligomers. These channels may differ in inactivation
(4, 18), permeation of organic substrates (5, 6, 19), single-
channel conductance, and rectification (17). The physiolog-
ical importance of LRRC8/VRAC channels is underscored by
the high lethality and multiple tissue abnormalities of
Lrrc8a/ mice (20) and their role in, for instance, apoptosis
and tumor drug resistance (5) and -cell insulin secretion
(22, 23).
LRRC8 proteins have four predicted transmembrane
domains that are followed by a large hydrophilic segment con-
taining 16 leucine-rich repeats (24) (hence LRRC for leucine-
rich repeat– containing). Analysis of databases (16) and exper-
iments with transfected cells (4, 7, 15) indicated that both N
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and C termini of LRRC8 proteins face the cytoplasm. This
finding agrees with the sequence homology of the LRRC8
transmembrane region to pannexin and innexin channels
(16). These three related protein families are believed to
share their protein fold with gap junction–forming connex-
ins (16) and CALHM channels (25) even though they dis-
play no significant sequence homology. Indeed, cryo-EM
revealed a connexin-like protein fold for Caenorhabditis
elegans innexin-6 (26) and most recently also for LRRC8
channels (27).
The structural determinants of VRAC function remain
largely unknown. Chimeras between the poorly inactivating
LRRC8C and the rapidly inactivating LRRC8E isoforms were
used to pinpoint residues involved in the voltage-dependent
inactivation of VRAC (18). Mutating some of these residues
(e.g. Lys-98), which are located in the C terminal portion of the
first extracellular loop (EL1), also mildly increased the I/Cl
permeability ratio of LRRC8A/E heteromers (18), and the
LRRC8A R103A mutant increased cation permeability of
LRRC8A/C heteromers (27). Small changes in the iodide/chlo-
ride permeability ratio (PI/PCl) were also observed when Thr-
44, located at the end of the first transmembrane span, was
mutated to cysteine (15). These residues might therefore
participate in forming the external portion of the pore as
recently confirmed by the cryo-EM structure of LRRC8
channels (27).
In the course of previous studies (4), we noticed that the
addition of epitopes to the N terminus of LRRC8A abolished
VRAC currents. This observation suggested an important role
of LRRC8 N termini in channel function. In this work, we there-
fore extensively mutated N-terminal residues of LRRC8A and
LRRC8C, coexpressed both subunits, and examined swelling-
activated ICl,vol currents. Cysteine modification experiments
and effects on permeation and gating suggest that the N termini
of LRRC8 proteins participate in forming the cytoplasmic por-
tion of the VRAC pore.
Results
Cotransfection of LRRC8/ HCT116 cells (in which all five
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Figure 1. Modifications of LRRC8 N termini interfere with channel function. A, plasma membrane localization of LRRC8A and LRRC8C-GFP or GFP-LRRC8C
upon coexpression in LRRC8/ HCT116 cells. LRRC8A was detected by LRRC8A antibody (red), and LRRC8C-GFP (top) or GFP-LRRC8C (bottom) was detected by
a GFP antibody (green). Yellow color indicates colocalization of LRRC8A and -C. B, typical current traces obtained with of LRRC8C-GFP (top) or GFP-LRRC8C
(bottom) upon coexpression with LRRC8A and 8-min exposure to 25% hypotonic solution (240 mosM). C, topology model of LRRC8 proteins with four TMs and
cytoplasmic LRRs (indicated by thick gray line). D, amino acid sequence alignment of N termini from human LRRC8A–E proteins. Conserved residues are shown
in white letters on gray background, and homologous amino acids are displayed in red. The first transmembrane span begins at about Trp-23. E, sequence of
generated N-terminal deletion and insertion (Ins) mutants of LRRC8A aligned to the WT sequence (top). The arbitrary uncharged and flexible peptide was
inserted after Gln-14 because the N termini of connexin 26 make a kink at Asn-14 to dip into the pore (31). F and G, current densities of hypotonicity-stimulated
ICl,vol at 80 mV of WT LRRC8A deletion/elongation mutants coexpressed with WT LRRC8C (F) or with LRRC8C carrying equivalent deletions/insertions (G). n.t.,
nontransfected controls. Error bars, S.D.; **, p  0.01; ***, p  0.001 versus WT (Dunn’s post hoc test after Kruskal–Wallis test; p values are corrected using the
Benjamini–Hochberg procedure). pF, picofarad.
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green florescent protein (GFP)-LRRC8A or LRRC8A-GFP or
with LRRC8A and either GFP-LRRC8C or LRRC8C-GFP
resulted in fluorescence at the outer cell membrane (Fig. 1A and
Fig. S1, A–C). Detection of GFP-tagged LRRC8C at the cell
surface suggested the formation of LRRC8A/C heteromers
because LRRC8C needs LRRC8A for plasma membrane
expression (4). However, only cells expressing the construct in
which the GFP had been fused to the C terminus rather than the
N terminus of LRRC8A (Fig. 1B) or LRRC8C (Fig. S1, Y and Z)
yielded swelling-activated ICl,vol currents. Currents elicited by
LRRC8A-GFP/LRRC8C or LRRC8A/LRRC8C-GFP were in-
distinguishable and displayed typical slow inactivation of
LRRC8A/C currents as reported previously (4, 18). Because
N-terminal addition of GFP to LRRC8A or LRRC8C interfered
with ionic currents but not protein localization, LRRC8 N ter-
mini might be critically involved in forming or regulating the
pore of VRAC channels.
All LRRC8 isoforms display short, 18-amino-acid-long N
termini before the first predicted transmembrane domain (Fig.
1, C and D). In addition to the obligatory initiator methionine,
Glu-6 and Gln-14 are conserved in all subunits, whereas other
parts of the N terminus display significant homology (Fig. 1D).
We cotransfected various N-terminal deletion or elongation
mutants of LRRC8A (Fig. 1E) with LRRC8C, either WT or car-
rying the same deletion or insertion (with GFP fused to the C
terminus of LRRC8C for identification of transfected cells as in
all subsequent experiments), into LRRC8/ HCT116 cells.
When coexpressed with WT LRRC8C, LRRC8A deletions
2– 4 and 3– 6 abolished ICl,vol, whereas 3– 4 and 5– 6 and
the insertion of 6 additional amino acids after Gln-14 were tol-
erated (Fig. 1F). However, when present in both isoforms, the
latter deletions and insertions also abolished currents (Fig. 1G).
In all cases, LRRC8C-GFP was detected at, or close to, the
plasma membrane (Fig. S1, E–N). Because LRRC8A is required
for the surface expression of LRRC8C (4), this localization sug-
gested that these deletions and the insertion did not interfere
with the assembly of LRRC8A/C heteromers. However, we can-
not exclude that the decrease in current amplitudes with some
of the mutants is due, at least in part, to decreased surface
expression.
Cysteine scanning of LRRC8 N termini and modification by
2-aminoethyl methanethiosulfonate (MTSEA) and Cd2
We then systematically mutated N-terminal residues in
LRRC8A and LRRC8C and assessed swelling-activated cur-
rents after coexpressing both subunits in LRRC8/ HCT116
cells (4). To explore the general validity of our findings, we also
studied several equivalent mutations in LRRC8D and -E. Ini-
tially we replaced N-terminal residues by cysteines because
changes in channel properties by cysteine-modification re-
agents may reveal the functional importance of the respective
residue and its exposure to a hydrophilic environment (28). We
singly replaced all residues from Ile-2 to Pro-15 in both
LRRC8A and LRRC8C by cysteines and coexpressed the
LRRC8A mutants with either WT LRRC8C or LRRC8C
mutated at the equivalent position. Whereas 10 of 14 LRRC8A
mutants yielded currents when coexpressed with WT LRRC8C
(Fig. S2A), only seven mutations gave functional channels when
introduced into both isoforms (Fig. 2A). Of note, none of the
cysteine mutants of the most N-terminal residues (positions 2,
3, and 4) gave currents.
We next explored the effect of the partially positively
charged, cell membrane–permeable cysteine-modification
reagent MTSEA (28) on currents of all functional “double
mutants” (i.e. LRRC8A/C heteromers carrying the same muta-
tion in both subunits) and on those functional “single” LRRC8A
mutants that gave currents only when coexpressed with
WT LRRC8C. Control experiments on WT LRRC8A/C–
transfected cells gave slow, variable effects on ICl,vol ampli-
tudes that sometimes included an initial current enhance-
ment followed by a slow decrease to roughly 75% of the
previous amplitude (Fig. 2, B and D). By contrast, currents
from several cysteine mutants were strongly and rapidly
reduced by MTSEA application (Fig. 2, C and D, and Fig.
S2B). This effect persisted following the washout of the re-
agent (Fig. 2C), suggesting that it was caused by a covalent
reaction of the engineered cysteine with MTSEA. The block-
ing effect of MTSEA was particularly striking with Y9C/Q9C
channels, which were almost completely and irreversibly
inhibited by MTSEA (Fig. 2, C and D). Interestingly, expo-
sure of the R8C double mutant to MTSEA, which may
restore a positive charge at position 8, strongly increased
ICl,vol to values that even exceeded WT currents severalfold
(Fig. 2D and Fig. S2C).
Cd2 inhibition of cysteine-substituted channels can dem-
onstrate the close vicinity of the substituted residues because
Cd2 binding requires multiple cysteines (29, 30). We had to
apply Cd2 to the N-terminal cysteine mutants from the intra-
cellular side, that is from the pipette. Therefore, inhibition of
VRAC may occur before or during its activation by cell swelling,
precluding observations of acute ICl,vol inhibition. Indeed, with
50 M Cd2 in the pipette, hypotonicity no longer elicited ICl,vol
from E6C/E6C, R8C/R8C, or Y9C/Q9C LRRC8A/C double
mutants (Fig. 2E). By contrast, currents from A11C/S11C,
Q14C/Q14C, and P15C/P15C mutant LRRC8A/C heteromers
were much less affected (Fig. 2E). Cd2 binding may occur
between the newly introduced cysteines, which are located at
equivalent positions, either between homologous (i.e. between
LRRC8A and -C) or the same type of subunits (e.g. between two
LRRC8A subunits). We therefore tested whether cysteines
needed to be inserted into both LRRC8 isoforms of the hetero-
meric channel. Whereas WT/Q9C channels were unaffected by
intracellular Cd2, Y9C/WT channels were efficiently blocked
by Cd2 (Fig. 2F), suggesting that Cd2 can be coordinated by
cysteines of identical isoforms. Assuming that the N termini of
LRRC8 proteins fold back into the pore as in connexin26 (31)
and innexins (26), we considered the possibility that the newly
introduced cysteines might coordinate Cd2 together with
transmembrane domain 2 (TM2) residues Cys-139 and Cys-
141 in LRRC8A and LRRC8C, respectively, that localize to, or
close to, VRAC’s permeation pathway (27). Mutating both cys-
teines to serines resulted in functional LRRC8A/C channels
as did N-terminal Y9C and Q9C mutations inserted in
LRRC8AC139S/LRRC8CC141S channels to yield LRRC8AY9C,C139S/
LRRC8CQ9C,C141S channels (Fig. 2F). The latter channels were
efficiently blocked by Cd2 (Fig. 2F), demonstrating that the
LRRC8 N termini in VRAC function
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inhibition of ICl,vol is not due to a cross-link of N termini to
the interior of VRAC. However, we cannot strictly exclude
that Cd2 binding occurred between the newly introduced
and other cysteines present in cytoplasmic parts of the chan-
nel that appear to have variable conformations (27). This
possibility might be rigorously eliminated only if all cytosolic
cysteines were replaced by other residues in both subunits.
Unfortunately, such cysteine-less mutants of LRRC8A and
LRRC8C failed to yield currents (data not shown). In any





























































































































































































Figure 2. Cysteine-scanning mutagenesis of LRRC8A/C N termini. WT and mutated LRRC8A and -C were coexpressed in LRRC8/ HCT116 cells, and
ICl,vol were elicited by hypotonicity as in Fig. 1B. A, mean maximum ICl,vol current densities (current normalized to respective cell capacitance) of
LRRC8A/C channels carrying cysteine substitutions in both LRRC8A and -C. Mutations are indicated on the vertical axis with native residues in LRRC8A
and -C separated by commas. The dashed line indicates mean ICl,vol density from WT/WT LRRC8A/C channels (WT measurements identical to Fig. 1F). B
and C, typical effects of MTSEA on ICl,vol mediated by WT/WT (B) or Y9C/Q9C (C) LRRC8A/C channels. Left, representative time course of currents at 80
mV taken from voltage ramps applied every 15 s. Each circle represents an individual measurement. Red and blue bars indicate application of 25%
hypotonic solution and hypotonic solution containing 200 M MTSEA, respectively. Right, typical current traces elicited by these ramps (shown below
the upper panel) in isotonic solution (Iso; a), full activation by hypotonic solution (Hypo; b), and at the end of the  4-min perfusion of MTSEA (c).
Capacitance of the cells in B and C: 18.2 and 18.8 picofarads (pF), respectively. D, mean effect of MTSEA on maximal ICl,vol currents of LRRC8A/C
heteromers carrying cysteine mutations in both LRRC8A and -C. Currents are normalized to those before MTSEA application. The dashed line represents
mean, normalized current density of MTSEA-exposed WT/WT channels. E, effect of 50 M intracellular Cd2 (applied in pipette solution) on ICl,vol density
from WT and mutant LRRC8A/C heteromers. F, effect of 50 M intracellular Cd2 (applied in pipette solution) on ICl,vol density from WT and mutant
LRRC8A/C heteromers (the values for WT and Y9C/Q9C are the same as in E) and for LRRC8AC139S/CC141S with and without Y9C/Q9C mutation. Error bars,
S.D.; *, p  0.05; **, p  0.01; ***, p  0.001 versus WT (in A and D, Kruskal–Wallis test, Dunn’s post hoc test; in E and D, Mann–Whitney test, false-discovery
rate controlled by Benjamini–Hochberg procedure).
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of LRRC8 proteins come close together in the multimeric
channel complex and might form part of the pore.
Mutations in Glu-6 change VRAC’s halide permeability
Mutations in pore-lining residues may change the selectivity
of the permeation pathway. We therefore examined whether
the functional LRRC8A/C heteromers carrying mutations
either in LRRC8A or in both isoforms (Fig. 2A and Fig. S2)
displayed altered I/Cl permeability ratios, which were calcu-
lated from the shift of reversal potentials (Erev) using the
Goldman–Hodgkin–Katz equation (Table 1). Whereas most
mutants had no or only marginal effects on VRAC’s I/Cl ion
permeability, mutating Glu-6 to Cys in both LRRC8A and
LRRC8C (LRRC8AE6C/CE6C channels) dramatically increased
PI/PCl from 1.29  0.01 to 2.29  0.10 (Fig. 3, A and D). Con-
comitantly the E6C/E6C mutation strongly decreased iodide
conductance (Fig. 3A), suggesting an increased affinity of iodide
to the mutant channel’s pore. This double mutation also
strongly increased SCN permeability while having only mod-
est effects on Br and none on F permeability and leaving the
selectivity sequence intact (Fig. 3E). Mutating Glu-6 in both
LRRC8A and -C to alanine, serine, or glutamine also increased
PI/PCl, albeit less so (Fig. 3D). Average magnitudes of their ICl,vol
were small, and E6K/E6K heteromers failed to yield measurable
currents (Fig. S3B).
The positively charged MTSEA reduced the magnitude of
the increase in I/Cl permeability of the E6C double mutant
(Fig. 3, B and D), whereas adding the membrane-impermeable
(28), negatively charged 2-sulfonatoethyl methanethiosulfon-
ate (MTSES) to the intracellular solution changed PI/PCl back
to WT values (Fig. 3, C and D). Strikingly, MTSES not only
restored the ion selectivity but also the current amplitude back
to WT levels (Fig. 3F), stressing the importance of a negative
charge at this position. Currents from LRRC8AE6C/CE6C chan-
nels were efficiently blocked by 4-[(2-butyl-6,7-dichloro-2-cy-
clopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]butanoic acid
(DCPIB) both in the absence and presence of MTSES, showing
that other properties such as inhibitor sensitivity were pre-
served in these channels (Fig. S4A). Interestingly, MTSES had
virtually identical effects on LRRC8AE6C/CE6C when applied
from the outside (Fig. S4, B and C). This suggests that this mem-
brane-impermeable reagent can penetrate deep into or through
VRAC’s pore. This was further substantiated by effects on R8C/
R8C and Y9C/Q9C mutants (Fig. S4). Indeed, MTSES has been
suggested to permeate LRRC8A/E channels (32), and MTS re-
agents can also permeate other Cl channels such as cystic
fibrosis transmembrane conductance regulator (33).
Glu-6 is conserved in all LRRC8 isoforms. Similar but less
pronounced changes in PI/PCl as in LRRC8AE6C/CE6C were
observed when LRRC8AE6C was coexpressed with LRRC8DE6C
or LRRC8EE6C (Fig. 3G). This result may not be explained
exclusively by the mutation of the common LRRC8A subunit
because Glu-6 must be mutated in both subunits to change the
anion permeability of LRRC8A/C heteromers. PI/PCl of
LRRC8AE6C/C and LRRC8A/CE6C heteromers was barely and
not significantly different from that of WT heteromers (Table
2). This suggests that the N termini of both LRRC8A and
LRRC8C contribute to the permeation pathway of LRRC8A/C
channels.
LRRC8 N termini modulate voltage-dependent inactivation
The permeability-changing E6C double mutation also dras-
tically changed the inactivation of LRRC8A/C heteromers (Fig.
4A) by shifting its voltage dependence about 80 mV to more
negative potentials (Fig. 4B). When inserted in only one of the
subunits, these mutations did not affect inactivation (Fig. 4B),
resembling their lack of effect on ion selectivity (Table 1). E6A/
E6A, E6S/E6S, and E6Q/E6Q LRRC8A/C double mutants dis-
played similar, albeit less pronounced, changes in inactivation
(Fig. S3, A and C). With the caveat that MTSES changed the
inactivation of WT LRRC8A/C heteromers, MTSES almost
abolished the difference in inactivation between WT/WT and
E6C/E6C heteromers, pointing again to a critical role of a neg-
ative charge at this position (Fig. S5, A and B).
The impact of E6C double mutants on inactivation depended
on the subunit combination. Whereas a more modest right shift
of the voltage dependence of inactivation was observed with
LRRC8A/E double mutants (Fig. 4C), no effect was seen for
LRRC8A/D (Fig. 4D).
N-terminal LRRC8 residues influence current rectification
Several charge-modifying mutations in the N terminus or
modification of N-terminally inserted cysteines increased the
outward rectification of ICl,vol. Eliminating the positively
charged Arg-8 by mutating it to cysteine or alanine in double
mutants increased outward rectification (Fig. 5, B and D). Like-
wise, introducing positive charges at Thr-5, either by exposing
T5C/WT LRRC8A/C channels to MTSEA or by introducing
the T5R mutation in both subunits, increased rectification by
selectively decreasing inward currents (Fig. 5, A, B, and D). Of
note, introduction of negative charges, by either treating
T5C/WT heteromers with MTSES or by introducing T5E
mutations into both subunits, also similarly increased rectifica-
tion (Fig. 5, E and D). It seems unlikely that increased rectifica-
tion is due to direct electrostatic interactions with the perme-
ating Cl ion because it was observed with insertions of either
positive or negative charges. We hypothesized that inserting
charges of equal signs into all six LRRC8 subunits may rather
cause conformational changes of the pore by electrostatic
repulsion of their N-terminal segments. Indeed, when we
inserted positive charges into one isoform but negative charges
into the other isoform as in T5E/T5R and T5R/T5E hetero-
Table 1
Erev and derived PI/PCl for cysteine mutants of LRRC8A/C channels
Mutants Erev PI/PCl n
mV
WT/WT 5.90  0.24 1.29  0.01 5
T5C/WT 7.13  1.80 1.35  0.10 4
E6C/E6C 19.90  1.04 2.29  0.10 7
L7C/WT 4.92  0.85 1.23  0.04 4
R8C/R8C 9.10  0.82 1.47  0.05 3
Y9C/Q9C 9.24  0.40 1.48  0.02 3
A11C/S11C 7.2  0.90 1.36  0.05 3
D12C/E12C 8.03  0.53 1.41  0.03 4
T13C/WT 6.6  1.20 1.30  0.06 3
Q14C/Q14C 4.92  0.85 1.23  0.04 4
P15C/P15C 7.38  0.57 1.37  0.03 4
LRRC8 N termini in VRAC function
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mers, rectification was reduced or restored to WT levels,
respectively (Fig. 5D).
Discussion
We identified the short hydrophilic N termini of LRRC8 pro-
teins as major determinants of the biophysical properties of
VRAC. Mutations of several of the 20 amino acids preceding
the first transmembrane domain and chemical modification of
N-terminal cysteine mutants not only changed current magni-
tudes but also inactivation gating and, most importantly, pore
properties such as iodide/chloride permeability ratios and rec-
tification. Our data are compatible with a model in which the N
termini of LRRC8 subunits line the cytoplasmic portion of the
pore, possibly by folding back into the ion translocation
pathway.
Structure and function of VRACs
Structure–function analysis of volume-regulated anion
channels is in its infancy as the molecular makeup of VRAC as
LRRC8 heteromers has only been discovered recently (4, 15).





































































































































Figure 3. Mutations of Glu-6 alter anion permeability of LRRC8 channels. A–C, typical ICl,vol I/V curves (elicited by voltage ramps from 100 to 100 mV
as in Fig. 2B) of WT/WT (left) and E6C/E6C (right) LRRC8A/C heteromers with 110 (blue) or 5 mM Cl and 105 mM I (red) extracellular Cl. Note the large increase
in iodide permeability in E6C/E6C mutants (A) that is not abolished by MTSEA (B) but is abolished by intracellular MTSES (1 mM) (C). D, PI/PCl obtained from shifts
in reversal potentials for WT/WT and E6C/E6C, E6A/E6A, E6S/E6S, and E6Q/E6Q LRRC8A/C channels (left). Intracellular MTSES (1 mM) restored WT permeability
ratio (right). E, mean permeability ratios (PX/PCl) for SCN
, Br, and F for WT/WT and E6C/E6C LRRC8A/C channels. F, restoration to WT levels of ICl,vol densities
of E6C/E6C LRRC8A/C channels by intracellular MTSES (left), which lacked an effect on WT/WT channels (right) (control measurements as in Figs. 1F (WT) and 2A
(E6C)). G, PI/PCl of WT/WT and E6C/E6C in LRRC8A/D and LRRC8A/E heteromers. Error bars, S.D.; *, p  0.05; **, p  0.01; ****, p  0.0001; *****, p  0.00001; ns,
not significant (in D, E, and G, unequal-variance t test for pairwise comparisons; in F, Mann–Whitney test; false-discovery rate controlled by Benjamini–
Hochberg procedure). pF, picofarad.
Table 2
Erev and PI/PCl for E6C mutants in LRRC8A/C channels
Mutants Erev PI/PCl n
mV
WT/WT 5.90  0.24 1.29  0.01 5
E6C/E6C 19.9  1.04 2.29  0.10 7
E6C/WT 7.31  1.0 1.36  0.05 4
WT/E6C 7.34  1.7 1.36  0.09 5
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Figure 5. N-terminal residues affect rectification of LRRC8 channels. A, I/V curves obtained from ramp protocols from T5C/WT LRRC8A/C channels in the
absence or presence of MTSEA or MTSES. B, I/V relationship of WT/WT, T5R/T5R, and R8C/R8C LRRC8A/C channels. C, mean ICl,vol densities of the indicated
channels at 120 mV. D, average rectification defined as the ratio between the maximum current at 120 and 120 mV. E, average rectification for WT/WT and
T5C/WT LRRC8A/C in the presence or absence of MTSES (the control values for WT the same as in D). Error bars, S.D.; *, p  0.05; **, p  0.01 (Kruskal–Wallis test,













































Figure 4. E6C mutations change inactivation of LRRC8 channels. A, representative current traces of WT/WT (left) and E6C/E6C (right) LRRC8A/C channels
with step protocols as in Fig. 1B. Dashed lines indicate zero current. B, voltage dependence of inactivation of WT and mutant LRRC8A/C channels. The ratio of
currents at the end of the 2-s voltage step (I2s) and beginning of the pulse (Imax) was fitted by the Boltzmann equation. C and D, voltage-dependent inactivation
of WT/WT and E6C/E6C LRRC8A/E (C) and LRRC8A/D (D) channels determined as in (B). Error bars, S.E.; numbers in parentheses, numbers of replicates.
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larity to connexins, which unambiguously assemble to hexam-
ers (31), LRRC8 proteins were postulated to form hexamers
(16). This hypothesis is compatible with experimental data
(6, 17, 34). Although cryo-EM indicated that invertebrate
innexin-6, which displays sequence homology to LRRC8 (16),
rather displays an octameric pore (26), cryo-EM recently con-
firmed that LRRC8/VRAC channels are hexamers (27). The
ratio of different subunits incorporated into single, physiologi-
cally always-heteromeric VRACs appears variable (6, 34).
Sequential coimmunoprecipitation experiments showed that
native VRACs can contain at least three different LRRC8 iso-
forms in a single channel (6). Even under the simplified condi-
tions of our experiments (expression of only two LRRC8 iso-
forms), cells might express many different VRACs that differ
not only in the stoichiometry of the two subunits but also in
their spatial arrangement. Whole-cell ICl,vol reflects averaged
properties of differently composed VRACs.
The LRRC8 isoform composition influences the voltage-de-
pendent inactivation (4, 18), substrate specificity (5, 6, 19), rec-
tification and single channel conductance (17), and sensitivity
to oxidation (32) of VRACs. Few studies have used mutagenesis
to identify functionally important LRRC8 residues. The
LRRC8A T44C mutant slightly increased VRAC’s PI/PCl per-
meability ratio from 1.29 to 1.59 when expressed in LRRC8A
knockdown cells (15); LRRC8AK98E, when expressed together
with the equivalent LRRC8EE91E mutant, slightly decreased
PI/PCl of LRRC8AK98E/EE91E channels from 1.25 to 1.12 (18);
and LRRC8AR103A increased the cation permeability of
LRRC8AR103A/C channels (27). Thr-44 is located at the end of
TM1, and Lys-98 and Arg-103 are located in EL1. In accord
with a recent cryo-EM structure (27), these data suggest that
these residues are located close to the extracellular opening of
the pore. Mutations in EL1 also drastically affected voltage-de-
pendent inactivation of VRAC (18).
LRRC8 N termini contribute to the pore of VRACs
The functional importance of LRRC8 N termini first became
apparent when fusion of epitopes to the N, but not the C, ter-
mini of LRRC8 proteins abolished VRAC currents. Several, but
not all, deletions and insertions of N-terminal amino acids also
abolished ICl,vol (Figs. 1, F and G, and 6), and single-cysteine
replacements at seven of 14 positions obliterated currents when
inserted into both subunits of LRRC8A/C channels (Figs. 2A
and 6). With one exception (Q14C/Q14C, which is rather close
to the first transmembrane span and did not change currents by
itself), reaction of functional LRRC8A/C cysteine double
mutants with MTSEA reduced or enhanced (R8C) ICl,vol ampli-
tudes (Fig. 2D), demonstrating that the mutated residues are
both accessible from the aqueous phase and important for
channel function. Although it is often inferred from channel
inhibition by MTS reagents that the cysteine-substituted resi-
due lines the pore (35–38), alternative interpretations seem
possible. However, the inhibition by Cd2 of several cysteine
mutants, including the crucial E6C/E6C and R8C/R8C substi-
tutions, requires a close proximity of the respective residues
(5–9 Å) (39). The Cd2 block of LRRC8AY9C/C heteromers
demonstrates that binding does not occur exclusively between
N termini of different isoforms. Although we cannot strictly
exclude that the introduced cysteines bind Cd2 together with
other cytoplasmic cysteines, these results suggest that N ter-
mini from different subunits of the hexameric channel come
together to form a narrow funnel that likely is part of the chan-
nel pore.
Compelling evidence for LRRC8 N termini lining the pore
comes from the drastically altered ion permeability of the E6C/
E6C mutant. The change in PI/PCl from 1.3 to 2.3 by far
exceeds those of the T44C (15) and K98E (18) mutants, which
change residues close to the extracellular face. The remarkable
restoration to WT values of both ion permeability and current
amplitudes by negatively charged MTSES but not by positively
charged MTSEA shows the importance of a negative charge at
position 6. Further strong evidence for a role of LRRC8 N ter-
mini in pore formation comes from the changes in current rec-
tification with charge-altering mutations at position 5 or 8
because in VRACs rectification is intrinsic to the pore (40, 41).
In conclusion, the analysis of our large set of mutants, summa-
rized in Fig. 6, strongly suggests that LRRC8 N termini contrib-
ute to the pore of VRACs.
Coupling between permeation and inactivation gating
Voltage-dependent inactivation of macroscopic VRAC cur-
rents involves the stepwise closure of individual channels that
show little gating at voltages not causing inactivation (42). The
large difference in inactivation between LRRC8A/C and
LRRC8A/E (4) was exploited to identify residues in EL1 as
major determinants of inactivation gating (18). Residues in that
segment also slightly changed PI/PCl, thereby linking perme-
ation and gating (18). Here, we observed a much stronger link
between permeation and gating. LRRC8A/C channels carrying
the E6C mutation in both subunits not only displayed strongly
altered I/Cl permeability but also a large shift in the voltage
dependence of inactivation to potentials that were even more
negative than observed with LRRC8A/E heteromers. MTSES
modification suggested that both changes depended on the
elimination of the negative charge at position 6. Like inactiva-
tion of WT/WT heteromers (4, 18), the effect of E6C mutations
also depended on the subunit composition. E6C double
mutants led to a marked left shift of voltage-dependent inacti-
vation with LRRC8A/C but a right shift with LRRC8A/E, chan-
nels that normally inactivate at very positive and more negative
voltages, respectively (4, 18).
(nearly) no current when mutated
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Figure 6. Summary of functional effects of N-terminal mutations in
LRRC8A and LRRC8C.
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Coupling of permeation and gating or inactivation in ion
channels is not unprecedented. For instance, constriction of the
selectivity filter was implicated in the inactivation of certain
potassium channels (43). Permeation and gating are intimately
linked in CLC chloride channels (44 –46), and the inactivation
of native VRAC currents in myoblasts and human embryonic
kidney and HL-60 cells has been reported to depend on chloride
(47, 48).
Comparison with pannexin, connexin, and CALHM channels
LRRC8 (VRAC), pannexin, innexins, connexin, and CALHM
channels share the same transmembrane topology and have
rather large pores that pass not only ions but also organic com-
pounds. Only LRRC8, pannexin, and innexin proteins share
sequence similarity (16), but all these channels, each of which
belongs to a distinct small gene family, share several other fea-
tures. Although previously shown only for connexins (31), these
channels were believed to be assembled from six identical or
homologous proteins (16, 25, 49) as recently confirmed for
LRRC8 channels (27). However, C. elegans innexins rather form
octameric hemichannels in hexadecameric gap junctions (26).
Gap junctions are formed by the reciprocal binding of two con-
nexin or innexin “hemichannels” expressed on two closely
apposed cells. Connexins can also form isolated hemichannels,
whereas pannexin, LRRC8, and CALMH channels do not form
gap junctions.
Analysis by both the substituted-cysteine accessibility
method (36, 38, 50) and ion permeability– changing substitu-
tion (51) and the crystal structure of Cx26 (31) revealed that the
second half of TM1 and part of EL1 line the external part of the
connexin pore. These structures also influence “loop gating” of
connexins (52). The substituted-cysteine accessibility method
similarly suggested the end of TM1 and part of EL1 as part of
the Panx1 pore (53). These findings are reminiscent of ion
permeability– changing mutations in LRRC8A at the end of
TM1 (15) and in EL1 (18) and the role of EL1 in VRAC inacti-
vation gating (18).
However, the similarities go much further. As shown here for
LRRC8 channels, in connexins the N termini also profoundly
affect pore properties as shown by mutations changing ion per-
meability (54) and rectification (51, 55). Voltage-dependent
“Vj” gating of connexins is strongly affected by N-terminal
charges, which may sense the electrical field across the mem-
brane (50). Mutations affecting connexin N termini have been
identified in various human diseases (56, 57) and stress the
importance of that region. The role of N termini in pannexins
and CALHM channels is less clear. Cysteine substitutions of
several N-terminal Panx1 residues abolished currents (53),
whereas exposure of N-terminal functional cysteine mutants to
a cysteine modification reagent failed to significantly inhibit
currents. Although showing that the N terminus is important,
these experiments fall short of demonstrating a role in pore
formation. Large parts of the CALHM N terminus can be
deleted without loss of currents, which, however, show changed
gating (58). Of note, the N termini of connexins, LRRC8 pro-
teins, and most innexins are of almost the same lengths, com-
patible with similar functions even in the absence of sequence
similarity, whereas pannexins, depending on the isoform, have
6 –23-residue-longer N termini (16).
The crystal structure of Cx26 revealed that the N termini of
the individual subunits fold back and line the cytoplasmic end
of the pore (31). Similarly, the N termini of innexins, which
show weak homology to LRRC8 proteins (16), dip into the pore
(26). Unfortunately, the N termini of LRRC8 proteins are not
resolved in the recently published cryo-EM structure (27). Our
results are compatible with a similar back-folding of LRRC8 N
termini. However, we cannot exclude the possibility that the N
termini rather protrude into the cytoplasm where they proba-
bly are surrounded by peptide chains from the TM2-TM3 loop
and the linker from TM4 to the leucine-rich repeats and pro-
vide an intracellular access funnel. Changes in voltage-depen-
dent gating would be somewhat more difficult to explain with
the second model because the N termini would not feel the
transmembrane voltage.
It should also be noted that, unlike channels with a highly
selective, narrow pore (21, 59), VRAC tolerated many different
point mutations and deletions in the N terminus without losing
its ability to conduct chloride. This relaxed structural require-
ment, which is also reflected in the lower degree of similarity
between LRRC8 N termini compared with transmembrane
spans, may be related to the fact that its apparently large pore
can also conduct many different organic compounds irrespec-
tive of charge (4 – 6, 34). A rather flexible arrangement of
LRRC8 N termini, as suggested by the present data, may explain
the inability to resolve them in cryo-EM studies (27).
In conclusion, our work demonstrates that the N termini of
LRRC8 subunits, which could not be resolved by cryo-EM (27),
participate in forming the cytoplasm-oriented part of VRAC’s
pore. They may fold back into the permeation pathway as
shown for connexins (31) and innexins (26). Permeability and
gating of LRRC8 channels are largely determined by their
extreme N termini but also by the end of transmembrane




Human LRRC8A (NM_019594), LRRC8C (NM_032270),
LRRC8D (NM_001134479) and LRRC8E (NM_025061) were
used as described before (4, 18). Point mutations were intro-
duced using QuikChange (Agilent) and verified by sequencing
the complete ORF.
Cell culture and transfection
HCT116 LRRC8/ cells (4, 18), with disruption of all five
LRRC8 genes, were maintained in McCoy’s 5A medium (PAN
Biotech) supplemented with 10% FBS (PAN Biotech) and 1%
penicillin/streptomycin at 37 °C and 5% CO2. For recording,
trypsin-treated cells were seeded onto gelatin-coated coverslips
and transfected using Lipofectamine 2000 (Life Technologies).
LRRC8C, -D, and -E were fused at the C terminus to GFP or
tdTomato and transfected together with LRRC8A at a 1:1 ratio,
respectively. Because LRRC8A is needed for the transport of
LRRC8B–E to the plasma membrane (4), cell-surface fluores-
cence of GFP or tdTomato, as observed on the patch-clamp
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setup, indicated the plasma membrane localization of LRRC8
heteromers. Such cells were used for whole-cell recordings
(18 –24 h after transfection).
Immunocytochemistry and antibodies
For immunocytochemistry, cells were fixed in precooled
methanol at 20 °C for 15 min 24 –36 h after transfection,
blocked for 30 min in blocking buffer (PBS containing 0.1%
saponin and 3% BSA), and then incubated sequentially for 1 h
each with primary and secondary antibodies in blocking buffer.
Images were acquired with an LSM 880 confocal microscope
with a 63	, 1.4 numerical aperture oil-immersion lens (Zeiss).
Rabbit polyclonal antibody against LRRC8A has been described
before (4), and GFP antibody was purchased from Aves (GFP-
1020). Secondary antibodies were conjugated to Alexa Fluor
488 or 546 (Molecular Probes).
Whole-cell voltage-clamp recordings
VRAC currents were recorded in the standard whole-cell
configuration at room temperature using an EPC-10 patch-
clamp amplifier and PatchMaster software (HEKA Elektronik)
or MultiClamp 700B patch-clamp amplifier/Digidata 1550B
digitizer and pClamp 10 software (Molecular Devices). Patch
pipettes were filled with solution containing 40 mM CsCl, 100
mM cesium methanesulfonate, 1 mM MgCl2, 1.9 mM CaCl2, 5
mM EGTA, 4 mM Na2ATP, and 10 mM HEPES (pH 7.2, 290
mosM) and had a resistance of 2– 4 megaohms. For Cd2 block
experiments, CaCl2 and EGTA were omitted from the pipette
solution, which then contained 40 mM CsCl, 110 mM cesium
methanesulfonate, 1 mM MgCl2, 4 mM Na2ATP, 10 mM HEPES
(pH 7.2, 290 mosM).
The isotonic extracellular solution contained 150 mM NaCl,
6 mM KCl, 1 mM MgCl2, 1.5 mM CaCl2, 10 mM glucose, and 10
mM HEPES (pH 7.4, 320 mosM). To elicit ICl,vol, cells were
exposed to a 25% hypotonic solution containing105 mM NaCl, 6
mM CsCl, 1 mM MgCl2, 1.5 mM CaCl2, 10 mM glucose, 10 mM
HEPES (pH 7.4, 240 mosM). Cesium was used instead of potas-
sium in the hypotonic external solution and the pipette solution
to block potential potassium current, which could be activated
during cell swelling. For measuring ion selectivity, NaCl in the
hypotonic solution was substituted with equimolar amounts of
NaI, NaSCN, NaBr, or NaF. To record ICl,vol, the standard pro-
tocol consisted of a 0.6-s step to 80 mV followed by a 2.6-s
ramp from 100 to 100 mV from a holding potential of 30
mV applied at 15-s intervals (as shown in Fig. 2B). Currents at
80 mV were used to analyze current density. To examine the
inactivation and rectification of VRAC, voltage protocols con-
sisted of a 2-s step protocol from 120 to 120 mV in 20-mV
increment from a holding potential of 80 mV applied every 5 s
(illustrated in Fig. 1B). Recordings were low pass–filtered at 2
kHz and sampled at 20 kHz.
Reagents and chemical modification
MTSEA and MTSES were purchased from Biotium and
stored at 20 °C as powder. Stock solutions of MTSEA and
MTSES were freshly made every day and kept at 20 °C.
Solution containing 200 M MTSEA or 1 mM MTSES was
freshly prepared. All other reagents were bought from
Sigma-Aldrich.
Data analysis
Relative anion permeabilities (PX/PCl) were calculated












where Erev is the shift in reversal potential, [Cl]hypo and
[Cl]subst are the extracellular Cl concentrations in the normal
and anion-substituted hypotonic saline (I, SCN, F, and
Br), and [X]subst is the concentration of the substituting anion.
R is the gas constant, T is the absolute temperature, and F is the
Faraday constant. Effects of acute MTSEA or MTSES applica-
tion were assessed as the ratio of current amplitude at the end of
application over steady-state current in hypotonic medium
immediately before application.
Liquid junction potentials were measured for all solutions
and corrected for in ion selectivity experiments. V1⁄2 for inacti-
vation was calculated as described (18). Because inactivation
was generally too slow for currents to reach steady state, we
used the ratio of currents at the end of the 2-s voltage step (I2s)
by the maximal current amplitude at the beginning of the volt-
age step (Imax) as the measure for inactivation. The time of
half-inactivation t1⁄2 was defined as the time point where the
inactivation reached half of the inactivation after 2 s. Boltz-
mann curve fitting and calculation of V1⁄2 were performed using
GraphPad Prism with the following fitting constraints: bottom
value less than 0.2 and top value greater than 0.9. Statistical
analysis was conducted with GraphPad Prism and SciPy library
for Python programming language (Python Software Founda-
tion). For pairwise comparisons of current densities and anion
permeability ratios the Mann–Whitney test and Welch t test,
respectively, were used to evaluate statistical significance. The
obtained p values were corrected for multiple comparisons
using the Benjamini–Hochberg procedure to control the false-
discovery rate when appropriate. Kruskal–Wallis test was used
for comparing multiple groups with Dunn’s post hoc test for
pairwise comparisons.
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